Study details N439K variant of SARS-CoV-2
Heparin targets coronavirus spike protein, research shows
28 January 2021Genetic analysis of symptoms yields new insights into PTSD
28 January 2021Study details N439K variant of SARS-CoV-2
An international team of researchers has characterized the effect and molecular mechanisms of an amino acid change in the SARS-CoV-2 Spike protein N439K. Viruses with this mutation are both common and rapidly spreading around the globe. The peer reviewed version of the study appears January 25 in the journal Cell.
